- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05272670
Digital Foot Self-Management Program for Older-Diabetes
Taiwanese Digital Foot Self-Management Program for Older-Diabetes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Literature reveals the needs for diabetic foot self-management intervention programs associated with positive changes in behavior. However, lack of studies focused on measure or improve health outcomes. Promoting effective diabetic foot care strategies in community is more critical than ever during a pandemic such as COVID.
This study are to evaluate the effect of a digital foot self-management program on self-efficacy, self-care behaviors, HbA1c and health promotion satisfaction for older adults with type 2 diabetes.
The contents of the 4-week program include: using a digital platform to providing foot self-management (checking conditions of foot, cleaning, cutting or removing corns and calluses, trimming, clipping nails, foot exercise, dietary related to foot care, foot care logs, etc). A developed digital platform as a self-help foot self-management education resource. The program specifically developed for older adults with diabetes to assist and management their own feet at homes. Week 1 face-to-face training session. Week 2 to week 4 following phone call once per week and LINE messages 3 times per week.by research nurse to encourage and monitor participant's compliance with the program at home by using the digital platform.
A total of 100 older adults with type 2 diabetes will be recruited from the 5 community clinics in southern Taiwan.A computerised random number generated by an independent statistician will be used to allocate each potential participant to the control or intervention group in a one-to-one ratio. All participants will be blinded to group allocation. Participants in control group will receive routine care provided in diabetes clinic, including routine check-ups and foot care education. While participants in the intervention group received the digital foot self-management program in addition to the routine care. Data will be collected at baseline and 4 weeks from baseline for self-efficacy, self-care behaviors,health promotion satisfaction and 12 weeks from baseline for HbA1c. The digital program will be delivered by trained registered nurse. A research assistant will be blinded to study protocol, who are employed to undertake data collection.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Shu-Ming Chen
- Phone Number: 7059 886-7-7811151
- Email: ft036@fy.edu.tw
Study Contact Backup
- Name: Shu-Hsien Lee
- Phone Number: 7059 886-7-7811151
- Email: vin6063168@yahoo.com.tw
Study Locations
-
-
-
Kaohsiung, Taiwan, 83102
- Recruiting
- Fooyin University
-
Contact:
- Shu-Ming Chen
- Email: ft036@fy.edu.tw
-
Contact:
- Shu-Hsien Lee
- Email: vin603168@yahoo.com.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have been diagnosed with type 2 diabetes.
- ≧65 years.
- Possess and able to use a smart device (e.g. Samsung Galaxy, iPhone, iPad, tabletop)
- Are able to speak and comprehend Chinese
Exclusion Criteria:
- Unable to perform physical activities.
- Cognitive impairments.
- Unable to read and speak Chinese
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental group
A 4-week digital foot self-management program will be provided to the participants in experimental group.
|
A 4-week digital foot self-management program based on Bandura's Self-Efficacy model.
The proposed functions include checking conditions of foot, cleaning, cutting or removing corns and calluses, trimming, clipping nails, foot exercise, dietary related to foot care, foot care logs, etc.
Which was developed for older adults with diabetic foot self-management by the study team.
Week 1 one-hour face-to-face training session after participant recruitment and allocation.
The outline session is 30 min to introduce key topics and function in the app platform, 15 min to install the app and to demonstrate the use of the app, 15min to discuss and practice.
Week 2 to week 4 following phone call once per week at the end of week and LINE messages 3 times per week.by
research nurse, who will encourage and monitor participant's compliance with the program at home by using the digital platform.
Participants are informed that technical phone support is available during the trial.
|
No Intervention: Control group
The control group received routine care that are required to attend the education sessions in the diabetes clinic according to their scheduled appointments.
Routine care included routine check-ups and foot care education.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Foot Care Self-Efficacy Scale
Time Frame: 4-week
|
Foot care self-efficacy was assessed using the Foot Care Self Efficacy Scale consisted of 16 items to measure individual's competence to manage foot care.
Cronbach's alpha was .72.
There are 16 items on the self-made scale in this study.
Scored using a five-point Likert scale: "completely disagree", "slightly disagree", "no opinion", "slightly agree" and "completely agree", with a maximum score of 80 and a minimum of 16; represented higher values indicate higher foot care self-efficacy (Chen, 2005).
The reliability Cronbach's alpha values were 0.82 in this study.
The scale was used at baseline and week 4 for participants in both control and experimental groups.
|
4-week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diabetic Foot Self-Care Behavior Scale
Time Frame: 4-week
|
Diabetic foot self-care behavior was assessed using the Diabetic Foot Self-Care Behavior Scale, a 7-item questionnaire.
Cronbach's alpha was .73.
The scale consists of seven questions, divided into two parts.
The first part was the number of days of foot care activities and the second part was the frequency of foot care activities.
On a 5-point Likert scale (never, 0 days a week= 1 point; rarely, 1-2 days a week= 2 points; sometimes, 3-4 days a week= 3 points; often, 5- 6 days a week= 4 points, 7 days a week= 5 points, with a maximum score of 35 and a minimum of 7. Represented higher scores indicate good foot self-care behavior (Chin & Huang, 2013).
Internal consistency Cronbach's alpha was .89 and test-retest reliability was .92 in this study.
The scale was used at baseline and 4-week for participants in both control and experimental groups.
|
4-week
|
HbA1c level
Time Frame: 12-week
|
HbA1c level was used to present glycemic control outcome.
The HbA1c level higher than 6.5% indicate worse glycemic control.
The outcome was measured at baseline and at 3 months.
Data were obtained from participants' medical records.
|
12-week
|
Health promotion satisfaction
Time Frame: 4-week
|
Health promotion satisfaction will be assessed using the questionnaire of Senior Technology Acceptance Chinese version developed by Chen (Chen et al., 2020).
Questionnaire consisted 4 domains: attitudinal beliefs, control beliefs, gerontechnology anxiety, health.
This outcome will be measured at week 4 for participants in experimental groups.
|
4-week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fooyin University, Nursing Department
Publications and helpful links
General Publications
- Chen SM, Lin HS, Atherton JJ, MacIsaac RJ, Wu CJ. Effect of a mindfulness programme for long-term care residents with type 2 diabetes: A cluster randomised controlled trial measuring outcomes of glycaemic control, relocation stress and depression. Int J Older People Nurs. 2020 Sep;15(3):e12312. doi: 10.1111/opn.12312. Epub 2020 Feb 26.
- Wu CJ, Atherton JJ, MacIsaac RJ, Courtney M, Chang AM, Thompson DR, Kostner K, MacIsaac AI, d'Emden M, Graves N, McPhail SM. Effectiveness of the cardiac-diabetes transcare program: protocol for a randomised controlled trial. BMC Health Serv Res. 2017 Feb 2;17(1):109. doi: 10.1186/s12913-017-2043-4.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TSMH IRB-20-084-B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Metabolism Disorders
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
University of LeipzigInstitut für Gesundheits- und Praxismanagement GmbHWithdrawn
-
Purdue UniversityAlmond Board of CaliforniaActive, not recruitingGlucose Intolerance | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
University of South CarolinaCompletedPhysical Activity | Sedentary Lifestyle | Metabolism Disorder, GlucoseUnited States
-
University of Missouri-ColumbiaCompletedGlucose | Blood Sugar; High | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
DLR German Aerospace CenterCompletedGlucose Metabolism Disorders | Local Glucose Uptake
-
Solvay PharmaceuticalsTerminatedDyslipidemia | Glucose Metabolism DisorderPoland, Croatia, Finland, France, Germany, Netherlands, Romania, Ukraine
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
Azienda Ospedaliero, Universitaria PisanaCompletedPregnancy Related | Maternal-Fetal Relations | Metabolism Disorder, GlucoseItaly
Clinical Trials on A digital foot self-management program
-
Lund UniversityVastra Gotaland Region; The Swedish Rheumatism AssCompleted
-
Chang Gung Memorial HospitalNational Science and Technology CouncilRecruitingOsteoarthritisTaiwan
-
Helen ObilorWounds CanadaCompleted
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)Active, not recruiting
-
Radboud University Medical CenterCompleted
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompletedChronic DiseaseUnited States
-
Scott and White Hospital & ClinicTexas A&M UniversityCompleted
-
Karolinska InstitutetKarolinska University Hospital; Tiohundra ABRecruiting
-
Anthem, IncUniversity of California, Irvine; HealthCore, Inc.; Apple Inc.; CareEvolution, LLCCompleted
-
The University of Texas Health Science Center at...National Center for Advancing Translational Sciences (NCATS)CompletedHypertensionUnited States